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ABSTRACT 
Objective: This study aims to evaluate the impact of pharmacist-led medication management clinics in improving medication knowledge among 
chronic kidney disease (CKD) patients. 
Methods: This was a retrospective study using a convenient sampling method. All CKD patients age 18 y above with complete pre and post 
knowledge assessment record were included. The pre-knowledge assessment was done at baseline while the post-assessment was done after a few 
sessions of medication knowledge teaching done by the clinical pharmacist using medication knowledge assessment form. Demographics data and 
pre-post knowledge scores were retrieved from patient’s electronic medical record system. All data were analysed using the Statistical Package for 
Social Sciences (SPSS) version 24. 
Results: The study shows a total of 13 patients, with the majority being Malay, male with a median age of 60. 84.6% of the patients were consuming 
more than 5 medications. While 53.9% of patients fall into CKD stage 4 and 5. Patient’s knowledge towards medications improved significantly with 
an increase in the median pre-knowledge score of 13 to post knowledge score of 18 (p<0.05) after completion of the session.  
Conclusion: From this preliminary evaluation, pharmacist-led medication management clinic resulted in significant improvement of medication 
knowledge which is further expected to improve medication adherence and delay the disease progression 
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INTRODUCTION  
Chronic kidney disease (CKD) is an alarming concern worldwide 
with high economic cost to the health system and are associated 
with increased risk of cardiovascular morbidity, premature 
mortality and decreased quality of life. Furthermore, due to the 
nature of the disease, it is usually asymptomatic until a later stage 
[1]. Global Burden of Disease Study in 2015 stated that kidney 
disease was the 12th most common cause of death, with almost 1.1 
million deaths worldwide [2]. Patients with CKD often received a 
complex medication regime with a high number of prescribed 
medications. Patient with CKD received an average of 12-19 
prescribed medications with more than 30% of patients have shown 
non-adherence to medications which result in poor treatment 
outcome and conclude that lack of medication knowledge with 
regards to the complex medication regimen and the desired 
treatment outcome was the main cause of this issue [3].  
The awareness and knowledge of CKD is crucial for patient 
involvement and adherence to the treatment, but CKD awareness 
assessed in primary care was found to be low even among kidney 
patients compared to awareness of diabetes and hypertension [4]. 
Pharmacist-managed clinic in Malaysia known as the medication 
therapy adherence clinic (MTAC) was introduced as part of the 
clinical pharmacy services to improve the quality, safety and cost-
effectiveness of patient care. Thus, in order to promote adherence 
and medication knowledge among CKD patients, pharmacy activities 
in outpatient settings play a huge role in ensuring the co-morbidities 
are appropriately evaluated and managed [5]. Specific roles taken up 
by pharmacist includes providing drug information, patient 
education and counselling, identifying drug-related problems, 
monitoring patient’s outcome and making an appropriate 
recommendation to invidualise patients medication regimen [6]. A 
cross-sectional suggest that knowledge of CKD among Malaysian 
population is still inadequate, especially those who are at risk of 
developing CKD [7]. Therefore, this study would be a benchmark to 
give a better view on the knowledge of the disease and medication 
as well as the impact of pharmacist role. The objective of this study 
was to evaluate the impact of pharmacists in improving medication 
knowledge among CKD patients. 
MATERIALS AND METHODS 
Study design and study site 
This was a retrospective study using convenient sampling method, 
conducted among CKD patients in a tertiary care hospital in 
Malaysia to evaluate the impact of pharmacist role in improving 
medication knowledge among CKD patients.  
Ethical approval  
Inform consent form was obtained from the participant who 
enrolled to the clinic. This study had been registered with the 
National Medical Research Register (NMRR) and been approved by 
the Medical Research and Ethical Committee (MREC) for ethical 
consent and Clinical Research Center (CRC) of Hospital. An NMRR ID 
no 18-1121-41154 was given to conduct the study.  
Eligibility criteria  
All CKD patients aged 18 y above who were enrolled in the program 
previously with complete pre and post knowledge assessment were 
eligible for the study. While patient with incomplete medical 
records, knowledge score and patients with mental health problems 
were excluded from the study.  
Data collection  
All the demographic data and knowledge assessment score 
throughout the sessions were collected from the patient’s electronic 
medical record system. A self-design data collection form was used 
to retrieve patient’s information such as demographic data and 
medical background. While for medication knowledge assessment, 
the pharmacist will ask about the dose/strength, frequency of 
administration, the purpose of use (indication) and method of 
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administration. 1 point given for each correct and zero marks for the 
wrong answer. The percentage score calculated based on the total 
number of correct answers divided with the number of questions 
asked multiply by 100. Clinical pharmacists will educate the patient 
on recognition of medication, common side effects of medication, 
disease management and self-management of the disease.  
Data analysis 
All data were analysed using Statistical Package for Social Sciences 
(SPSS) for Windows version 24.0. Descriptive statistics, such as 
median±interquartile range, were used to summarize data. With 
statistical significance set at p<0.05, Wilcoxon signed-rank test was 
used to determine the significant difference of pre and post score of 
the knowledge shown by the CKD patients.  
RESULTS 
The study sample comprised of 13 CKD patients aged between 19 to 
80 y, with the median age of 60.00 y. Elderly patients (≥ 60 y) were 
more than half of the study population (53.8%). Gender distribution 
showed almost even distribution of male and female patients. The 
racial distribution showed that 69.2% of CKD patients were Malays 
followed by non-Malays such as Chinese (n=2), Indian (n=1) and 
others (n=1). There were larger group of CKD patients (84.6%) 
taking more than 5 medications compared to those having less than 
5 medications. While the studied population was categorized into 
their respective CKD staging according to KDIGO classification. The 
staging was almost evenly distributed, with the majority of CKD 
patient’s stage 4 and 5 at 53.9%. 
  
Table 1: Socio-demographic information 
Variables  Frequency (%) Median (IQR) 
Age (Years)  60 (30) 
Age Group    
Non-elderly (18-59) 6 (46.2)  
Elderly (≥ 60) 7 (53.8)  
Gender   
Male 7 (53.8)  
Female 6 (46.2)  
Ethnicity    
Malay 9 (69.2)  
Non-Malay 4 (30.8)  
No of medications    
<5 2 (15.4)  
≥ 5 11 (84.6)  
CKD stage    
1 1 (7.7)  
2 4 (30.8)  
3 1 (7.7)  
4 4 (30.8)  
5 3 (23.1)  
 
Table 2: Pre and post knowledge of the patients 
N=13 
Variable  Pre-score median (IQR)  Post-score median (IQR) Z-statistic P-valuea 
Knowledge Score 13 (9.5) 18 (2.5) -3.070 0.002* 
aWilcoxon Signed Rank Test, *p<0.05 is statistically significant 
 
Table 2 shows the median knowledge score at the baseline was 13 
while after completion of pharmacist-led educational intervention, 
the knowledge score improve to 18. A Wilcoxon signed-rank test 
was conducted to evaluate the impact of attending the CKD MTAC on 
the knowledge of the CKD patients. There was a statistically 
significant increase in the knowledge score between before MTAC 
and after MTAC session (p<0.05).  
DISCUSSION 
The elderly with age greater than 60 y contributes to the majority of 
the patient population followed by those ages from 18 to 59 y. A 
systemic review stated that on the prevalence of CKD in population-
based study concludes that the prevalence of CKD varied strongly 
with age and increased with age [8]. This study also showed that 
there was high male CKD patient compared to female. This is 
contrary to the findings by Hill et al. (2016), which deduced that 
CKD was more prevalent in women than in men with a prevalence of 
14.6% compared to 12.8%, respectively. However, male patients 
were found to have a significantly higher progression from late stage 
of CKD to ESRD compared to female patients [9]. This study reveals 
that the majority of the CKD patients were at the late stage of CKD, 
which were stage 4 and 5. Similar trend was observed in a study 
conducted at Penang General Hospital, which saw a higher 
prevalence of stage 5 CKD patients [10]. 
Most importantly, there was a statistically significant increase in 
knowledge score (p<0.05). This was comparable to a study 
conducted by Ghimirey et al., (2013), in which pharmacist 
counseling was evaluated in the improvement of knowledge, 
attitude and practice in CKD patients [11]. The impact of 
pharmaceutical care in improving knowledge and medication 
adherence in CKD patients were observed which revealed that 
during initial knowledge assessment shows poor result and 
significant improvement in patient knowledge after being provided 
with patient education through patient information leaflets [12]. 
Impact of pharmacists had also been recorded in a systemic review 
by which shows they had reviewed pharmacists’ interventions in the 
management of patients with CKD and concluded that positive 
association between pharmacist intervention and clinical outcomes 
improvement [13]. 
LIMITATIONS 
To the best of our knowledge, this is the first study to 
comprehensively address the importance of the pharmacist-led 
educational intervention among CKD patients. However, there are 
some limitations in our study, such as there is no control group 
used; therefore, there were no direct comparisons between two 
groups of patients, one group involved with pharmacist intervention 
and the other group follows the conventional method.  
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CONCLUSION 
Chronic kidney disease is a serious growing health concern worldwide. 
This study conclude that pharmacist can produce a significant 
improvement in patients’ knowledge. Moreover, this study strongly 
shows that further understanding of the disease and medications 
regarding CKD is an integral part of the management of CKD with the 
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